PFIZER INC: Detrol LA Patent Suits v. Sandoz, Mylan Pending

Patent infringement actions filed by Pfizer Inc. against Sandoz and Mylan Pharmaceuticals Inc. relating to Detrol LA (tolterodine) are ongoing.

In March 2008 and May 2010, respectively, Sandoz and Mylan notified…

PFIZER INC: Relpax Patent Suits v. Three Companies Pending

Patent infringement actions filed by Pfizer Inc. against Apotex Inc., Apotex Corp. and Teva USA relating to Relpax (eletriptan) are pending.

In June 2010, the Company received notices from Apotex Inc.…

PFIZER INC: King’s Avinza Patent Breach Suit v. Actavis Settled

A patent infringement suit filed by King Pharmaceuticals, Inc. and Elan Pharma International Ltd. against Actavis, Inc. relating to Avinza (morphine sulfate) was settled in July 2011. The Company acquired…

PFIZER INC: Wyeth, Nycomed’s Protonix Patent Suits Pending

Patent infringement suits filed by Wyeth and Nycomed GmbH against Teva USA and Teva Pharmaceutical Industries, Sun Pharmaceutical Advanced Research Centre Ltd. and Sun Pharmaceutical Industries Ltd. relating to Protonix…

ABBOTT LABS: Bayer’s Humira(R) Patent Suits Settled in 2Q11

Patent infringement cases filed by Bayer Healthcare LLC against Abbott Laboratories relating to Humira(R} were settled during the second quarter of 2011.

In its 2010 Form 10-K, Abbott reported that lawsuits…

ABBOTT LABS: Niaspan(R) Patent Suit v. Lupin Settled in 2Q11

A patent infringement suit filed by Abbott Laboratories against Lupin Pharmaceuticals and Lupin Limited relating to Niaspan(R) was settled and dismissed with prejudice during the second quarter of 2011.

In its…

ABBOTT LABS: Sept. 12 Deadline Set for HUMIRA Ruling Review

Centocor Inc. has until Sept. 12, 2011 to ask the U.S. Supreme Court to review the Federal Circuit’s decision in a patent infringement suit it filed against Abbott Laboratories.

In April…

ABBOTT LABS: Gets Favorable Ruling in Medinol Patent Suit

Abbott Laboratories obtained favorable ruling in a patent infringement suit filed by Medinol Limited.

In its Form 10-Q for the quarter ended March 31, 2011, Abbott reported that in March 2011…

ABBOTT LABS: Seeks to Enforce Androgel(R) Patent Rights

Abbott Laboratories is seeking to enforce its patent rights relating to testosterone gel product, a drug that the Company sells under the trademark AndroGel(R).

In a case filed in the United…

ABBOTT LABS: Tricor(R) Patent Suits v. Impax, Teva Settled

Patent infringement suits filed by Abbott Laboratories against Impax Laboratories and Teva Pharmaceuticals USA Inc. relating to Tricor(R) were settled and dismissed with prejudice during the second quarter of 2011.

In…

Page 4 of 33« First...«23456»...Last »